Skip to main content

T3165 - Naloxone, 4mg Nasal Spray, FDA-Approved, for the New Jersey Department of Human Services

Division of Purchase and Property

Deadline
December 4, 202613 days left
Contract value
Value not stated in the notice
Set-aside
None stated

What it is

NJSTART 26DPP01283: T3165 - Naloxone, 4mg Nasal Spray, FDA-Approved, for the New Jersey Department of Human Services Department: DPP - Division of Purchase and Property. Purchase method: Contract. Pre-bid conference: Please refer to the Bid Solicitation.. Attachments: T3165 Bid Amendment 2 - Responses to eQA and Revisions to the Bid Solicitation 10.29.26.pdf; T3165 26DPP01283 Revised Bid Solicitation 10.29.2026; T3165 Bid Amendment 1 - Revised BOD 10.09.26; T3165 26DPP01283 Revised Bid Solicitation 10.09.2026; T3165 26DPP01283 Bid Solicitation 8.20.2026; T3165 26DPP01283 State-Supplied Price Sheet 8.20.26.

From the official listing, in the buyer's own words.

Who can bid

  • Businesses registered to sell to this buyer

The notice names no set-aside, so it is not limited to one type of firm.

What it is worth

Value not stated in the notice

The listing states no figure and we hold no past awards to go by, so we show none rather than guess.

Notice details

Notice type
01 - 01 - RFP
Line of work
human services

Rules on AI-written applications

No AI policy found — check the funder's guidelines